Clinical Study

Many herbal supplements claim to safely and effectively relieve joint pain and inflammation, and some have testimonials to support this. However, very few companies are willing to put their products to the test and clinically verify their claims. If they are not willing to scientifically test their product, how do you know if they are really telling the truth?

Here at Nutreance, we do things differently. When designing RediMove, we decided that we only wanted to offer it to the public if it was clinically proven to relieve joint pain and improve mobility versus placebo.

Once the formula was finalized, we enlisted Princeton Consumer Research to conduct a placebo-controlled clinical study over the course of 30 days. 50 men and women between the ages of 18 and 65 took part in the study. 25 participants were given RediMove, while 25 other participants were given a placebo. Each was instructed to take the product daily and keep a daily journal of their experience.

The statistically significant results were as follows:

  • More than 4 out of 5 participants experienced joint pain relief and improved mobility after taking RediMove for just 2 weeks, significantly outpacing placebo.
  • This statistically significant level of joint pain relief was sustained throughout the remainder of the 30 day trial for more than 85% of participants.
  • Over 85% of participants felt they could return to exercise and activities they previously avoided.
  • None of the participants reported any negative side effects.

For more details, click here to view the complete results of the study.